胰腺黏液性囊性肿瘤的超声表现

目的探讨胰腺黏液性囊性肿瘤(MCNs)的超声表现。方法回顾性分析42例经手术病理证实的MCNs的超声表现。结果 MCNs多发生于中年女性,大部分位于胰体尾部,肿瘤体积较大,边界清晰,多数有包膜。42例MCNs中,22例为囊性或以囊性为主;18例囊实混合性;2例实性。病理诊断良性病变24例,交界性7例,恶性11例。超声诊断:20例考虑为良性,22例考虑恶性,超声诊断恶性MCNs的敏感度为77.78%(14/18),特异度为66.67%(16/24)。结论 MCNs超声图像表现复杂,肿物内分隔厚度、是否存在实性部分有助于鉴别良、恶性病变。     

扩散加权成像对胰腺黏液性囊性肿瘤良恶性的鉴别诊断价值

目的:探讨扩散加权成像(diffusion weighted imaging,DWI)对胰腺黏液性囊性肿瘤良恶性的鉴别诊断价值。方法:回顾性分析45例胰腺黏液性囊性肿瘤的DWI图像,测量肿瘤表观弥散系数(apparent diffusion coefficient,ADC)、最小ADC值(ADC_(min))和最大ADC值(ADC_(max))。比较胰腺良恶性黏液性囊性肿瘤的平均ADC(ADC_(mean))、ADC_(min)和ADC_(max),并应用受试者工作特征(receiver operating characteristics,ROC)曲线评价其诊断性能。结果:胰腺良性黏液性囊性肿瘤(n=27)的ADC_(mean)高于恶性肿瘤组(n=18;3.34×10~(-3)mm~2/s vs 2.36×10~(-3)mm~2/s,P0.000 1),ADC_(mean)鉴别肿瘤良恶性的ROC曲线下面积(AUC)为0.91。胰腺恶性黏液性囊性肿瘤的ADC_(min)低于良性黏液性囊性肿瘤(1.24×10~(-3)mm~2/s vs 2.54×10~(-3)mm~2/s,P0.000 1),ADC_(min)鉴别肿瘤良恶性的AUC为0.94。胰腺良恶性黏液性囊性肿瘤的ADC_(max)差异无统计学意义(3.71×10~(-3) mm~2/s vs 3.86×10~(-3) mm~2/s)。结论:DWI中ADC_(mean)和ADC_(min)对胰腺黏液性囊性肿瘤良恶性有鉴别价值。     

Surgery of cystic neoplasms

Neoplastic cysts of the pancreas have been recognized since the nineteenth century, and although differences between neoplastic and proliferative cysts were acknowledged, they were treated similarly, first by marsupialization and later by internal drainage. Increased awareness of the malignant potential of neoplastic cysts, as well as advances in surgical techniques, made excision the preferred treatment for these lesions as early as the 1940s, but errors in diagnosis were frequent, and even to this date, continue to account for cases of pancreatic cystic tumors treated by drainage.     

Nonmucinous cystic pancreatic neoplasms

This article discusses serous cystadenomas, the most common of the nonmucinous cystic lesions of the pancreas. These microcystic lesions were previously known as "glycogen-rich" cystadenomas because of the presence of glycogen within the cyst epithelium. A small percentage of these lesions are macrocystic, and it may be difficult to differentiate them from mucinous lesions; however, endoscopic ultrasound guided fine needle aspiration can provide diagnostic material from the cyst fluid. The second most common nonmucinous cyst, the islet cell tumor, is also discussed. These rare cystic tumors may or may not be accompanied by excess hormone production. The prognosis for the rare cystic tumors is good if they are resected successfully.     

Mucinous cystic neoplasm of the liver: A case report

BACKGROUNDMucinous cystic neoplasm of the liver (MCN-L) is a cyst-forming epithelial neoplasm. The most distinguishing feature is the ovarian-type subepithelial stroma on pathological examination. CASE SUMMARYAn abdominal ultrasound incidentally revealed a liver tumor in a 32-year-old woman. Physical and laboratory examination results did not reveal any abnormalities. Enhanced abdominal computed tomography (CT) revealed a cystic space measuring 7.2 cm × 5.4 cm in the liver. Subsequent CT showed an increase in tumor size. Thus, we performed surgical resection of the tumor and gallbladder. Postoperative histopathological examination confirmed the diagnosis of MCN-L. At the 6-mo of follow-up, no recurrence was observed on ultrasound or CT.CONCLUSIONSince preoperative diagnosis of MCN-L is difficult, active surgery is recommended and helpful for the diagnosis and treatment of MCN-L.     

Histology of cystic tumors of the pancreas

The cystic tumors of the pancreas constitute a considerable diagnostic challenge because of their overlapping clinical, radiologic, and pathologic features. They may be difficult to differentiate from one another and from benign lesions such as pseudocysts. Because many of the tumors in this group are potentially curable, correct diagnosis is essential for proper patient management. Even when correctly diagnosed, thorough microscopic evaluation is required for the mucin-producing tumors to correctly determine their degree of malignant progression in any given case. Most recently, molecular analysis of these tumors has demonstrated definitively that the serous and mucinous types of cystic neoplasms of the pancreas are unrelated pathogenetically. Conversely, molecular data indicate similarities between the mucinous types of cystic tumors and ductal adenocarcinoma of the pancreas, but the essential molecular differences that underlie the differences in biological behavior are as yet undetermined.     

胰腺导管内乳头状黏液性肿瘤的多层螺旋CT诊断

目的探讨胰腺导管内乳头状黏液性肿瘤在多层螺旋CT上的影像特点。方法回顾性分析30例经手术切除和病理学证实的胰腺导管内乳头状黏液性肿瘤的临床、多层螺旋CT影像学资料,结合CT血管造影(computed tomography angiography,CTA)、多平面图像重组和二维曲面重组等影像技术观察其影像学表现,分析影像学表现与病理结果的相关性。结果 30例胰腺导管内乳头状黏液性肿瘤的多层螺旋CT诊断:主胰管型13例,分支胰管型9例,混合型8例;术后病理结果显示胰腺导管内乳头状黏液性瘤8例,胰腺交界性或低度恶性乳头状黏液瘤8例,胰腺导管内乳头状黏液癌14例。结论胰腺导管内乳头状黏液性肿瘤具有特征性的影像学表现,螺旋CT能协助诊断并能对其分型,运用CTA、多平面图像重组和二维曲面重组等影像技术有助于术前评估肿瘤的良、恶性。     

Diagnosis of cystic neoplasms with endoscopic ultrasound

From the data that are currently available, it appears that EUS can help to reliably distinguish between the majority of benign and neoplastic cystic lesions. In equivocal cases, or cases where a high suspicion for malignancy exists, the use of EUS-guided FNA for obtaining cytology and cystic fluid for analysis of various tumor markers, gives the best diagnostic yield. Occasionally, despite a complete evaluation of a cystic mass, the cyst type may not be determined. The decision regarding further management of these lesions should be based on a combination of factors including symptoms, cyst size, EUS morphology and the patient's overall medical condition. In the case of symptomatic, large, or suspicious lesions where the patient is a good surgical candidate, surgical resection should be performed. However, it becomes more difficult in the case of asymptomatic, small cystic lesions where the patient is not an optimal surgical candidate. In the latter scenario, applying EUS criteria for follow-up of small pancreatic cystic lesions as reported by Ikeda et al can help in the decision-making process. In this study, Ikeda et al reported on 31 patients with pancreatic cystic lesions of unknown etiology that were followed-up with semi-annual EUS exams over a 3-year period. In 87.1% of these lesions, the size was less than 2 cm. Their criteria included 1) a clear thin wall, 2) smooth contour, 3) round or oval shape, 4) no septum or nodules, 5) asymptomatic clinical presentation, and 6) no findings of chronic pancreatitis. The cystic lesions remained stable in 30/31 patients, and only one lesion increased in size. This lesion was resected and was found to be a retention cyst. We are optimistic that the role of EUS in the management of cystic neoplasms will continue to evolve and expand as future studies evaluate the clinical utility of imaging modalities for the optimal practice algorithm for managing these neoplasms.     

Squamous cell carcinoma of the pancreas with cystic degeneration

Most nonendocrine pancreatic neoplasms are adenocarcinomas of ductal cell or acinar origin. Primary carcinomas of the pancreas with squamous differentiation are rare enough to warrant a search for other primary tumors. In the past few decades, well-documented individual reports and large series reviews support the view that these squamous neoplasms are indeed of pancreatic origin and not uncommonly exhibit cystic degeneration. Late manifestation and unfavorable prognosis seem to be uniform features. We report a case with many of these features.     

Papillary cystic neoplasm of the pancreas: Radiological findings

We report a series of 10 papillary cystic neoplasms of the pancreas evaluated in our institution. The lesions are analyzed in retrospect to define the existence of eventual specific imaging patterns as well as to point out the existing problems of differential diagnosis versus other pancreatic tumors.     

Serum alphafetoprotein in cystic fibrosis of the pancreas.

Serum alphafetoprotein concentrations were measured by three different types of radioimmunoassay in 30 patients with cystic fibrosis of the pancreas and in 55 controls. The highest value obtained in cystic patient was 10.2 ng/ml and in a control 10.8 ng/ml. These are within published normal limits. Previously reported large increases in serum AFP in patients with cystic fibrosis and in heterozygote carriers have not been confirmed.     

Endoscopic ultrasound techniques for pancreatic cystic neoplasms

The role of EUS and EUS FNA in the evaluation of cystic pancreatic lesions is evolving. The detailed imaging provided by EUS and hence the ability to target the biopsy at suspicious areas within the pancreatic cystic lesion may prove to be invaluable. Improvements in EUS equipment will further secure the role of this technology when evaluating these patients.     

Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography

BACKGROUND AND STUDY AIMS: In mucin-producing tumors of the pancreas, diagnosis using endoscopic retrograde cholangiopancreatography (ERCP) is limited to cystic formations that communicate with the main pancreatic duct. Magnetic resonance cholangiopancreatography (MRCP) is a new, sophisticated method which is currently under evaluation. The authors describe the usefulness of MRCP in diagnosis of mucin-producing tumors. PATIENTS AND METHODS: Six patients with mucin-producing tumors were investigated using MRCP and ERCP. Imaging was compared with surgery and histopathological examinations. RESULTS: Three patients were found to have mucinous cystadenomas (MC), two patients had intraductal papillary mucinous tumors (IPMT) and one patient had a cystadenocarcinoma. MRCP demonstrated the cystic formations in all patients. Magnetic resonance imaging (MRI) showed contrast-mediated enhancement of the cystic wall in patients with MC, and visualized the pancreatic ducts completely in patients with IPMT. ERCP failed to visualize the cystic lesion in one patient with MC of the pancreatic tail. Furthermore, ERCP showed evidence of IPMT in dilated main ducts with multiple filling defects but did not visualize the ducts completely. CONCLUSIONS: MRCP provides visualization of pancreatic ducts, extraductal variations, and cystic formations more completely than ERCP does. It avoids complications seen in ERCP. MRCP may replace ERCP in the evaluation of mucin-producing tumors of the pancreas.     

29例胰腺黏液性囊性肿瘤的超声诊断

目的探讨胰腺黏液性囊性肿瘤的超声表现与诊断。方法对2000年6月至2008年12月中山医院外科手术病理证实的29例胰腺黏液性囊性肿瘤的超声表现进行回顾性分析。结果超声表现囊性或囊性为主22例,囊实性实性为主5例,实性2例;病理诊断良性20例,交界性4例,恶性5例;超声诊断良性病变12例,恶性病变6例,良恶性诊断符合率72.4%(21/29),其中9例诊断囊腺瘤。结论胰腺黏液性囊性肿瘤的超声声像图表现多样,图像典型时超声可作出正确诊断,声像图表现不典型时要诊断黏液性囊性肿瘤及其良恶性确有困难。     

Molecular diagnosis of solid and cystic lesions of the pancreas

Pancreatic cancer presents at a clinically advanced stage. Diagnosis often is delayed in those who undergo several negative investigations, and at times, the diagnosis ultimately is made at surgery. Tumor suppressor-linked microsatellite allelic loss analysis appears to improve the diagnostic accuracy of inconclusive cytology specimens. Science, however, still suffers from the lack of a reliable biomarker for the purpose of screening and early detection. The continued study of sera and pancreatic juice hopefully will lead to the discovery of molecular biomarkers capable of diagnosing preclinical disease in at-risk groups.The ability to predict the underlying biologic behavior of pancreatic cystic neoplasia is less than ideal. Tumor suppressor-linked microsatellite allelic loss and telomerase analysis show promise, but they have not been studied extensively. Proteomic analysis of pancreatic cyst fluid, although not yet reported, also may prove valuable in guiding clinical management.